Last reviewed · How we verify
AT-02
At a glance
| Generic name | AT-02 |
|---|---|
| Sponsor | Attralus, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Impact of Treadmills and Cooler Environments for Office Workplaces on Ergonomics, Heating Energy Requirements, Performance, as Well as Back and Cardiometabolic Health (NA)
- Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS (PHASE2)
- Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers (NA)
- A Study of AT-02 in Subjects With Systemic Amyloidosis. (PHASE2)
- Effect of Breast Milk Circadian Properties on Infant's Growth Parameters and Absorption of Nutrients (NA)
- Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis (PHASE1)
- Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AT-02 CI brief — competitive landscape report
- AT-02 updates RSS · CI watch RSS
- Attralus, Inc. portfolio CI